Roivant Sciences

Roivant Sciences, founded in New York, is a biopharmaceutical company dedicated to advancing promising drug candidates to improve patient care. The company's core mission is to reinvent the discovery, development, and commercialization of new medicines through its unique model of creating agile, focused subsidiaries known as "Vants." Roivant leverages technology across all stages of drug development and focuses on high-quality execution and rigorous capital allocation to maximize the potential of its drug candidates.

Notable affiliated individuals include founder Vivek Ramaswamy, who has been instrumental in shaping the company's strategic direction. Roivant has attracted significant investment from prominent venture capital firms and has achieved several key milestones, including multiple positive Phase trials and FDA approvals. The company's innovative approach has had a substantial impact on the biopharmaceutical industry, accelerating the development of transformative medicines and improving patient outcomes.